Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

369
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
369
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

707
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
707
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between Parkinson's Disease and Cancer: New Findings and Possible Mediators.

International journal of molecular sciences·2024
Same author

Nuclear α-synuclein regulates transcription and affects neuronal differentiation.

The FEBS journal·2024
Same author

Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era.

Biomedicines·2023
Same author

α-Synuclein and Mechanisms of Epigenetic Regulation.

Brain sciences·2023
Same author

Synucleins: New Data on Misfolding, Aggregation and Role in Diseases.

Biomedicines·2022
Same author

Phytochemicals as Regulators of Genes Involved in Synucleinopathies.

Biomolecules·2021

Related Experiment Video

Updated: Dec 30, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.0K

Caveolin: A New Link Between Diabetes and AD.

Andrei Surguchov1

  • 1Department of Neurology, Kansas University Medical Center, Kansas City, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA. asurguchov@kumc.edu.

Cellular and Molecular Neurobiology
|January 25, 2020
PubMed
Summary

Alzheimer's disease and type 2 diabetes share links, with caveolin-1 potentially bridging these conditions. This protein may influence disease pathways involving mitochondria and endoplasmic reticulum.

Keywords:
Alzheimer’s diseaseAmyloid precursor proteinBeta-amyloidCaveolinsDiabetes mellitusTau

More Related Videos

Barnes Maze Testing Strategies with Small and Large Rodent Models
12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

43.3K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K

Related Experiment Videos

Last Updated: Dec 30, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.0K
Barnes Maze Testing Strategies with Small and Large Rodent Models
12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

43.3K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K

Area of Science:

  • Neuroscience
  • Endocrinology
  • Cell Biology

Background:

  • Alzheimer's disease (AD) and type 2 diabetes mellitus (T2D) are prevalent aging-related diseases with significant health impacts.
  • Patients with T2D exhibit an increased risk for AD, and glucose metabolism issues are common in AD patients, suggesting shared underlying mechanisms.
  • While the comorbidity of AD and T2D is well-documented, the precise inter-relational mechanisms remain unclear.

Purpose of the Study:

  • To investigate the potential role of caveolin-1 (CAV-1) in the association between Alzheimer's disease and type 2 diabetes.
  • To explore how CAV-1 might mediate the link between these two prevalent conditions.

Main Methods:

  • Preliminary investigations were conducted by examining patients diagnosed with Alzheimer's disease.
  • Subsequent validation and confirmation of initial observations were performed using an established animal model.

Main Results:

  • Emerging evidence suggests that caveolin-1 (CAV-1), a protein involved in cellular signaling, may play a crucial role in the comorbidity of AD and T2D.
  • Initial findings in AD patients were corroborated by studies in an animal model, strengthening the hypothesis of CAV-1's involvement.

Conclusions:

  • Caveolin-1 is implicated as a potential key player in the shared pathophysiology of Alzheimer's disease and type 2 diabetes.
  • The influence of CAV-1 in both T2D and AD may involve critical cellular organelles, specifically mitochondria and the endoplasmic reticulum.